-
Mashup Score: 0Once cushioned from lawmaker scrutiny, hospitals see a shift - Roll Call - 11 month(s) ago
The shift follows the COVID-19 pandemic, when Congress poured $178 billion into helping hospitals offset financial losses and care for more patients.
Source: Roll CallCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0House Energy and Commerce Committee Looks to Reign In PBM Power - 11 month(s) ago
The role of pharmacy benefit managers in the health care space is being scrutinized more than ever before.
Source: Drug TopicsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 6
United States House Committee on Oversight and Accountability
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Pharmacy Benefit Manager Group Decries Oversight Hearing Agenda - 12 month(s) ago
The trade group representing the nation’s top pharmacy benefit managers is redoubling criticism of congressional scrutiny into the industry, taking aim at a House panel for not inviting the organization’s members to testify in a hearing Tuesday.
Source: news.bloomberglaw.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 9
United States House Committee on Oversight and Accountability
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
For patients who have undiagnosed cancer, a months-long delay due to new prior authorization requirements for colonoscopies could be disastrous.
Source: STATCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4FTC Deepens Inquiry into Prescription Drug Middlemen - 12 month(s) ago
As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issu
Source: Federal Trade CommissionCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5FTC Sues to Block Biopharmaceutical Giant Amgen from Acquisition That Would Entrench Monopoly Drugs Used to Treat Two Serious Illnesses - 12 month(s) ago
The Federal Trade Commission is seeking to block biopharmaceutical giant Amgen Inc.
Source: Federal Trade CommissionCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 7myCOA - COA - 12 month(s) ago
CMS’ Decision Will Cause Serious Harm and Disruption to the Treatment of Medicare Seniors with Cancer Statement from Ted Okon, Executive Director, Community Oncology Alliance Yesterday evening, the Centers for Medicare & Medicaid Services (CMS) informed the Community Oncology Alliance (COA) that it would not rescind its deeply flawed 2021 “Frequently Asked Question” (FAQ) that oncology practices…
Source: mycoa.communityoncology.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Copay Accumulators - 1 year(s) ago
Ask your lawmakers to support the Help Ensure Lower Patient Copays Act (HELP Copays Act)
Source: asco.quorum.usCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We’re urging Members in the House of Reps to cosponsor H.R. 830, the Help Ensure Lower Patient Copays Act, to stop health plans & #PBMs from using copay accumulators to pocket patients’ copay assistance payments. 🗣️ Add your voice ➡️ https://t.co/TPyAfKLWDW #ASCOAdvocacySummit https://t.co/c7EmdnXdx3
-
It's about time these large health systems face the music of transparency. They hate the light as mush as the #PBMs. And they are dragging down out true community hospitals, especially those struggling in rural areas. https://t.co/ipSsyfb0oT